FNCB Bancorp (NASDAQ:FNCB) reported quarterly earnings of $0.28 per share. This is a 9.68 percent decrease over earnings of $0.31 per share from the same period last year.
Incannex Submits IND Application To The FDA For Dronabinol-Based Drug For Obstructive Sleep Apnea
Incannex Healthcare Limited (NASDAQ: IXHL) (ASX:IHL) has successfully submitted an Investigational New Drug (‘IND’) application to the US Food and Drug Administration for IHL-42X for treatment of obstructive sleep apnea.
